Inhibitors of Beta2-Microglobulin Protein Aggregates (ProteoTech)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameInhibitors of Beta2-Microglobulin Protein Aggregates (ProteoTech)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionR7V inhibitors
TargetsBeta-2-microglobulin
Therapy Area/IndicationsAmyloidosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesProteotech
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesProteotech
Active IndicationsN/A
Inactive IndicationsAmyloidosis

Other Information

ATC CodeN/A
Related LinksN/A